Teriparatide for Postsurgical Hypoparathyroidism

Overview

About this study

Will teriparatide ( Forteo) shorten the length of hospitalization post thyroidectomy in patients with symptomatic hypoparathyroidism

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion criteria:

  • Patients post bilateral thyroid bed surgery (cancer, Graves' disease, multinodular goiter)
  • Symptomatic hypocalcemia
  • Total calcium < 8 mg/dL persisting after 24 hours of therapy with calcitriol (minimum 0.25 mcg twice a day) and calcium supplementation (minimum 1.5 grams of elemental calcium per day)
  • Parathyroid hormone (PTH) level below low end of normal range

Exclusion criteria:

  • Renal failure
  • Any prior parathyroid pathology
  • Pre-existing hypercalcemia
  • Metabolic bone diseases other than osteoporosis
  • Paget's disease
  • Ongoing therapy with Forteo for osteoporosis
  • Active non-thyroidal malignancy or suspicion of residual thyroid malignancy
  • History of skeletal malignancies, primary or metastatic
  • Pregnancy
  • Active or recent urolithiasis
  • Digitalis therapy
  • Patients at increased baseline risk for osteosarcoma, i.e. family history of osteosarcoma or prior radiation therapy involving the skeleton
  • Pediatric populations
  • Unexplained elevations of alkaline phosphatase

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Marius Stan, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20154090

Mayo Clinic Footer